平衡痴呆症患者癌症治疗中个人需求与服务需求

2021-10-26 小文子 MedSci原创

为痴呆症患者提供以人为中心的护理时,护理结局和满意度提高。

癌症和痴呆是老年人的两种常见疾病,受癌症和痴呆共病影响的人数较多,为伴有复杂合并症(包括痴呆)的老年人群提供癌症护理和治疗是日益增长的挑战。尤其对患者及其家属来说,管理多种疾病比较困难,这更增加了护理的复杂性。

International Journal of Nursing Studies杂志发表的一项研究旨在了解从事肿瘤护理的工作人员如何平衡这些患者的独特和复杂需求,并探索对痴呆症患者的癌症护理经验。

纳入标准为确诊或怀疑患有痴呆症(FAST评分为4分以上)的人,且目前或最近(2年内,并伴有记忆问题)接受过癌症治疗或护理。最终13名痴呆和癌症患者、18名亲属和19名工作人员参与本研究。采用参与者观察、非正式对话、半结构化访谈和医学笔记回顾等方法,共进行37次访谈,由于不同的沟通能力和参与者偏好,访谈持续时间9分钟到122分钟。

研究人员提取了三个关键主题:

1.提供以人为本的护理

详细了解患者的认知障碍,以及对接受癌症治疗和护理的患者产生的影响,有助于以人为中心的护理。在癌症治疗过程中,工作人员为痴呆症患者提供个性化和弹性支持。良好沟通是为痴呆症患者提供以人为中心护理的核心。

2.管理目标和流程

以积极主动的方式提供护理使得痴呆症患者及其家人获益。

3.人员、场所和流程的连续性

护理人员应认识到痴呆症患者从熟悉中获益,并努力提供连续性护理。

为痴呆症患者提供以人为中心的护理时,护理结局和满意度提高。护理人员应平衡对痴呆症患者个性化和灵活支持的需求与癌症护理和治疗的管理目标和流程。并强调人员、地点和过程连续性的重要性。

对于护理人员和患者来说,平衡和管理个人需求和服务需求是困难的。提高对痴呆症的认识、识别和记录将有助于护理人员了解患者的具体需求。需要进一步研究上述因素如何影响痴呆患者及其家属寻求癌症诊断和治疗的决策。

原文出处:

Alys Wyn Griffiths, Laura Ashley, et al, Balancing the needs of individuals and services in cancer treatment for people with dementia: A focused ethnographic study, International Journal of Nursing Studies,2021, https://doi.org/10.1016/j.ijnurstu.2021.104006.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1844322, encodeId=aed41844322e6, content=<a href='/topic/show?id=06a2e1405a8' target=_blank style='color:#2F92EE;'>#癌症治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71405, encryptionId=06a2e1405a8, topicName=癌症治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Fri Jan 07 20:34:13 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1836284, encodeId=d04b18362848e, content=<a href='/topic/show?id=4613e1212fc' target=_blank style='color:#2F92EE;'>#痴呆症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71212, encryptionId=4613e1212fc, topicName=痴呆症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=726030, createdName=Boyinsh, createdTime=Tue Aug 09 12:34:13 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070423, encodeId=dcf010e0423a3, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab095705058, createdName=isFran, createdTime=Mon Nov 15 14:37:50 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1246324, encodeId=6b45124632483, content=老年性痴呆,未来还是希望借助神经电生理吧,也许更为有效!, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuro.Dr, createdTime=Tue Oct 26 15:34:13 CST 2021, time=2021-10-26, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1844322, encodeId=aed41844322e6, content=<a href='/topic/show?id=06a2e1405a8' target=_blank style='color:#2F92EE;'>#癌症治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71405, encryptionId=06a2e1405a8, topicName=癌症治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Fri Jan 07 20:34:13 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1836284, encodeId=d04b18362848e, content=<a href='/topic/show?id=4613e1212fc' target=_blank style='color:#2F92EE;'>#痴呆症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71212, encryptionId=4613e1212fc, topicName=痴呆症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=726030, createdName=Boyinsh, createdTime=Tue Aug 09 12:34:13 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070423, encodeId=dcf010e0423a3, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab095705058, createdName=isFran, createdTime=Mon Nov 15 14:37:50 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1246324, encodeId=6b45124632483, content=老年性痴呆,未来还是希望借助神经电生理吧,也许更为有效!, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuro.Dr, createdTime=Tue Oct 26 15:34:13 CST 2021, time=2021-10-26, status=1, ipAttribution=)]
    2022-08-09 Boyinsh
  3. [GetPortalCommentsPageByObjectIdResponse(id=1844322, encodeId=aed41844322e6, content=<a href='/topic/show?id=06a2e1405a8' target=_blank style='color:#2F92EE;'>#癌症治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71405, encryptionId=06a2e1405a8, topicName=癌症治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Fri Jan 07 20:34:13 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1836284, encodeId=d04b18362848e, content=<a href='/topic/show?id=4613e1212fc' target=_blank style='color:#2F92EE;'>#痴呆症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71212, encryptionId=4613e1212fc, topicName=痴呆症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=726030, createdName=Boyinsh, createdTime=Tue Aug 09 12:34:13 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070423, encodeId=dcf010e0423a3, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab095705058, createdName=isFran, createdTime=Mon Nov 15 14:37:50 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1246324, encodeId=6b45124632483, content=老年性痴呆,未来还是希望借助神经电生理吧,也许更为有效!, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuro.Dr, createdTime=Tue Oct 26 15:34:13 CST 2021, time=2021-10-26, status=1, ipAttribution=)]
    2021-11-15 isFran

    收藏

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1844322, encodeId=aed41844322e6, content=<a href='/topic/show?id=06a2e1405a8' target=_blank style='color:#2F92EE;'>#癌症治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71405, encryptionId=06a2e1405a8, topicName=癌症治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbf451, createdName=陈吴1234, createdTime=Fri Jan 07 20:34:13 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1836284, encodeId=d04b18362848e, content=<a href='/topic/show?id=4613e1212fc' target=_blank style='color:#2F92EE;'>#痴呆症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71212, encryptionId=4613e1212fc, topicName=痴呆症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=726030, createdName=Boyinsh, createdTime=Tue Aug 09 12:34:13 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070423, encodeId=dcf010e0423a3, content=收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab095705058, createdName=isFran, createdTime=Mon Nov 15 14:37:50 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1246324, encodeId=6b45124632483, content=老年性痴呆,未来还是希望借助神经电生理吧,也许更为有效!, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuro.Dr, createdTime=Tue Oct 26 15:34:13 CST 2021, time=2021-10-26, status=1, ipAttribution=)]
    2021-10-26 neuro.Dr

    老年性痴呆,未来还是希望借助神经电生理吧,也许更为有效!

    0

相关资讯

《癌症发现》发表EXALT-1试验结果,显示人工智能功能性精准医疗平台可改善癌症治疗转归

该研究表明首个人工智能功能性精准医疗平台可指导晚期血液系统癌症患者的治疗选择并改善转归

CA:COVID‐19大流行期间某些癌症治疗延迟并不会影响结果

这两个研究似乎表明,短延迟,尤其是在面对像新冠肺炎这样的外部挑战,可能不会产生明显的长期影响。

默克在ASCO21上呈报的肿瘤产品阵容数据突显癌症治疗的重大进展

关键性研究的新分析强调BAVENCIO®在晚期尿路上皮癌不同亚组治疗中的独特临床获益

Seminars in Cancer Biology:肠道微生物有助于抗癌免疫调节

肠道微生物区系在影响肿瘤发生和癌细胞对治疗药物的反应方面具有重要作用。微生物区系对癌症的显著影响推动了操纵微生物区系来预防和治疗癌症的努力。微生物操作可以作为传统癌症治疗的辅助手段。

武田的EXKIVITY™ (mobocertinib)成为美国FDA首次核准的专为EGFR外显子20插入+ NSCLC患者设计的口服治疗药物

该核准的依据是1/2期试验的结果,该结果显示,缓解有临床意义,中位缓解持续时间(DoR)约1.5年

Nat Nanotech:诱骗癌细胞摄取化疗药物,增强癌症治疗效果

近日,哈佛医学院/麻省总医院的研究团队在 Nature Nanotechnology 期刊上发表了题为:Therapeutically reprogrammed nutrient signalling